抗人蛋白酶激活受体4单克隆抗体的制备与鉴定

目的:制备抗人蛋白酶激活受体4(PAR4)单克隆抗体(mAb).方法:以hPAR4为免疫原免疫BALB/c小鼠,运用杂交瘤技术制备抗PAR4 mAb.采用Ig类与亚类鉴定试剂盒鉴定mAb的Ig类型,采用ELISA、点杂交、免疫组化染色法(人结肠、扁桃体及包皮组织)、流式细胞术、激光共聚焦显微镜(CLSM)技术鉴定mAb的特异性.结果:获得3株可稳定分泌抗PAR4 mAb的杂交瘤细胞,其分泌的mAb均为IgM.免疫组化染色表明,mAb将人结肠组织中的腺上皮细胞、疑似肥大细胞和淋巴细胞,扁桃体组织中的淋巴细胞和包皮组织中的肥大细胞染成褐色.流式细胞术分析显示,3株mAb与A549细胞的PAR4均呈阳性反应.CLSM观察发现,荧光标记的阳性反应物主要位于A549细胞的胞质和胞膜上.结论:成功制备了抗PAR4 mAb,为进一步的研究工作提供了有用的试剂.     

抗人白介素-28A单克隆抗体的制备与鉴定

目的制备抗人白介素-28A（hIL-28A）单克隆抗体（mAb）。方法以hIL-28A融合蛋白为免疫原免疫BALB／c小鼠，运用杂交瘤技术制备抗hIL-28A mAb。采用Ig类与亚类鉴定试剂盒鉴定mAb的Ig亚类，通过ELISA、Western blot、免疫组化染色法、流式细胞分析、激光共聚焦显微镜技术鉴定mAb的特异性。结果获得2株稳定分泌抗hIL-28A mAb的杂交瘤细胞，但2株mAb均与hIL-29有弱交叉反应。2株mAb的类别均为IgM。Western blot分析表明，此mAb所识别的靶分子的相对分子质量（Mr）约为19000。免疫组化染色表明，mAb与包皮和肺组织中的上皮细胞、结肠组织中的疑似巨噬细胞呈阳性反应。流式细胞仪分析显示，2株mAb与人脐静脉内皮细胞系HUVEC细胞的反应均呈阳性。激光共聚焦扫描显微镜观察到荧光标记的阳性反应物主要位于HUVEC细胞胞浆内。结论成功地制备抗hIL-28A mAb，为病毒感染性疾病、肿瘤和其他疾病的研究提供新的手段。     

抗蛋白酶激活受体?鄄2单克隆抗体的制备与鉴定

目的:制备出一种具有多种用途的抗蛋白酶激活受体-2(PAR-2)单克隆抗体(mAb).方法:用人工合成的11肽PAR-2作为免疫原,采用皮下多点注射方法免疫BALB/c小鼠,取其脾细胞与NS-1骨髓瘤细胞融合,杂交瘤细胞采用间接ELISA法筛选.通过ELISA、Dot blot、免疫组化染色、流式细胞分析、激光共聚焦显微镜技术鉴定mAb的特异性.结果:获得1株可稳定分泌抗:PAR-2 mAb的杂交瘤细胞.其分泌的mAb为IgM型,ELJSA法检测杂交瘤细胞培养上清效价为1:16;点杂交分析表明此抗体可特异性结合PAR-2;免疫组化染色显示该单克隆抗体与人肺组织中的肺泡上皮细胞和平滑肌细胞,结肠组织中的腺上皮细胞和疑似淋巴细胞,扁桃体中的淋巴细胞,包皮组织中的鳞状上皮细胞呈阳性反应;流式细胞仪分析显示与人肺腺癌细胞系A549细胞中的PAR-2呈阳性反应;激光共聚焦扫描显微镜观察发现荧光标记的阳性反应物位于A549细胞的胞膜和胞浆.结论:成功地制备出可用于免疫组化和点杂交的抗PAR-2单克隆抗体,为PAR-2相关性疾病的研究提供了有用的工具.     

抗人胰岛素样生长因子-1单克隆抗体的制备与鉴定

目的:制备稳定分泌抗人胰岛素样生长因子-1(hIGF-1)单克隆抗体(mAb)的杂交瘤细胞系,并对其分泌的mAb进行鉴定.方法:用纯化后的hIGF-1重组蛋白免疫Balb/c小鼠,利用杂交瘤细胞融合技术制备抗hIGF-1的mAb,用Western blot法鉴定mAb的特异性,用间接ELISA法检测mAb腹水效价及mAb的亲和力,杂交瘤细胞染色体分析,鉴定Ig亚类.结果:获得2株能稳定分泌抗hIGF-1的mAb杂交瘤细胞系,Western blot分析显示,该mAb能与具有生物学活性的成熟IGF-1蛋白结合.腹水mAb效价可达6×104.mAb相对亲和力为2.1×109/mol～7.8×109/mol.2株单抗属IgM亚类.染色体分析符合杂交瘤细胞特征.结论:成功制备出抗hIGF-1的2株mAb杂交瘤细胞,为进一步用于hIGF-1的临床检测和实验研究创造了条件.     

鼠抗人PD-L1单克隆抗体的制备及鉴定

目的 制备鼠抗人PD-LI单克隆抗体(mAb)并对其生物学特性进行鉴定.方法 以重组GST-PDL1融合蛋白免疫BALB/c小鼠,建立可稳定分泌抗PD-L1 mAb的杂交瘤细胞株.用ELISA及Western blot鉴定mAb的特性.并测定其效价及Ig亚类.用免疫组织化学和流式细胞术分析其与干扰素-γ(IFN-γ)诱...     

烯酰辅酶A水合酶单克隆抗体的制备与鉴定

目的 制备抗人烯酰辅酶A水合酶(ECH1)的单克隆抗体(mAb)并进行初步鉴定.方法 将正常成人肝组织匀浆离心并分离线粒体,用线粒体总蛋白免疫BALB/c小鼠,采用杂交瘤技术制备mAb.并通过问接ELISA法、Western blotting及免疫组化的方法对mAb进行特性鉴定,通过免疫沉淀联合质谱、Uni-ZAP XR表达文库筛选鉴定抗原.结果 获得1株可稳定分泌抗人ECH1 mAb的杂交瘤细胞系.mAb的Ig亚类(型)为IgG1(K),该mAb可用于EUSA检测、Western blotting、免疫组化和免疫沉淀实验.结论 成功制备了抗人ECHI的mAb,为ECH1的研究提供了有力的工具.     

PAGE-4单克隆抗体的制备及表达分布

目的:制备抗PAGE-4 mAb并鉴定其特异性及敏感性,应用该抗体在蛋白质水平上分析PAGE-4在正常与疾病组织中的表达. 方法:以PAGE-4为抗原免疫BALB/c小鼠,利用杂交瘤技术建立稳定分泌抗PAGE-4 mAb的杂交瘤细胞系. 采用Western Blot及ELISA等方法鉴定抗体的特异性和敏感性. 应用正辛酸-饱和硫酸铵方法纯化抗体. 利用免疫组织化学方法对PAGE-4在正常与疾病组织中的表达进行分析. 结果:获得4株分泌特异性抗PAGE-4 mAb的杂交瘤细胞株,mAb具有较高的特异性与敏感性. 在正常男女生殖系统组织如:睾丸、前列腺、子宫中以及正常胰腺组织中有PAGE-4的表达,在前列腺癌、子宫内膜腺癌中PAGE-4高表达. PAGE-4在蛋白质水平上的表达格局与以往有关PAGE-4在mRNA水平上的报道一致. 结论:成功获得抗PAGE-4 mAb,为研究PAGE-4定位及功能提供了重要工具.     

抗创伤弧菌mAb的制备与鉴定

目的: 制备抗创伤弧菌mAb并用于创伤弧菌感染的快速诊断.方法: 用灭活创伤弧菌免疫Balb/c小鼠,采用杂交瘤技术制备抗创伤弧菌的mAb,ELISA法用于mAb的Ig效价,亚类及特异性鉴定.结果: 获得了2株可持续分泌抗创伤弧菌mAb的杂交瘤细胞株.结论: 获得的高特异性的抗创伤弧菌mAb不仅为创伤弧菌感染的快速诊断奠定了坚实的基础,而且为其进一步的治疗方面的研究提供了理论依据.     

抗HBsAg单克隆抗体的制备与生物学特性的鉴定

目的:制备分泌抗HBV S蛋白的单克隆抗体的杂交瘤细胞株,并鉴定其特性,为建立快速诊断HBV感染的方法奠定基础.方法:以重组乙肝疫苗免疫BALB/c小鼠,通过细胞融合建立了能稳定分泌抗HBsAg单抗的杂交瘤细胞株,利用间接ELISA技术和Western blot进行单抗特异性的鉴定,同时采用间接ELISA方法鉴定mAb的Ig亚类,检测mAb的效价及相对亲和力.结果:获得1株可分泌特异性mAb的杂交瘤细胞4D2,其抗体亚类为IgG1型,腹水效价为1:10(6),相对亲和力在10(5)以上.结论:成功地制备出抗HBV S蛋白的单克隆抗体,为建立快速特异检测HBV感染的实验方法提供了有力的工具.     

人睾丸特异表达基因TDRG1 单克隆抗体的制备及鉴定

目的：构建原核质粒表达TDRG1重组蛋白,制备其单克隆抗体（mAb）并鉴定其生物学特性。方法：用逆转录聚合酶链反应法从成人睾丸组织中扩增TDRG1编码序列,将其克隆到pET21原核表达载体,在大肠杆菌BL21（DE3）内进行诱导表达TDRG1重组蛋白。以纯化后的重组蛋白免疫BALB/C小鼠,利用杂交瘤细胞融合技术制备单克隆抗体（mAb）。ELISA法检测杂交瘤细胞分泌mAb的效价和类型,Western 印迹和免疫组织化学染色鉴定mAb的特异性。 结果：成功构建了pET21/TDRG1原核表达质粒并获得纯度较高的重组蛋白。筛选出2株能稳定分泌抗TDRG1的单克隆抗体杂交瘤细胞系,其效价比高达1∶1.6×106,免疫球蛋白类型均为IgG1类。Western 印迹和免疫组织化学染色显示该mAb能特异结合成人睾丸组织中的TDRG1蛋白。结论：所获得的重组TDRG1蛋白纯度高,免疫抗原性强,并成功制备了抗TDRG1的单克隆抗体。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.